Effect of dietary docosahexaenoic acid (DHA) in phospholipids or triglycerides on brain DHA uptake and accretion
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Tracer studies suggest that phospholipid DHA (PL-DHA) more effectively targets the brain than triglyceride DHA (TAG-DHA), although the mechanism and whether this translates into higher brain DHA concentrations are not clear. Rats were gavaged with [U-(3)H]PL-DHA and [U-(3)H]TAG-DHA and blood sampled over 6h prior to collection of brain regions and other tissues. In another experiment, rats were supplemented for 4weeks with TAG-DHA (fish oil), PL-DHA (roe PL) or a mixture of both for comparison to a low-omega-3 diet. Brain regions and other tissues were collected, and blood was sampled weekly. DHA accretion rates were estimated using the balance method. [U-(3)H]PL-DHA rats had higher radioactivity in cerebellum, hippocampus and remainder of brain, with no differences in other tissues despite higher serum lipid radioactivity in [U-(3)H]TAG-DHA rats. TAG-DHA, PL-DHA or a mixture were equally effective at increasing brain DHA. There were no differences between DHA-supplemented groups in brain region, whole-body, or tissue DHA accretion rates except heart and serum TAG where the PL-DHA/TAG-DHA blend was higher than TAG-DHA. Apparent DHA β-oxidation was not different between DHA-supplemented groups. This indicates that more labeled DHA enters the brain when consumed as PL; however, this may not translate into higher brain DHA concentrations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chowdhury, R., Warnakula, S., Kunutsor, S., Crowe, F., Ward, H. A., Johnson, L., Franco, O. H., Butterworth, A. S., Forouhi, N. G., Thompson, S. G., et al. (2014) · Annals of Internal Medicine · doi:10.7326/m13-1788 · Cited by 1,139
Fatty acid composition of brain phospholipids in aging and in Alzheimer’s disease
Söderberg, M., Edlund, C., Kristensson, K., & Dallner, G. (1991) · Lipids · doi:10.1007/bf02536067 · Cited by 667 · cited 2×
“found in patients with Alzheimer’s disease [7-11] (reviewed in [12]).”
BackgroundSchuchardt, J., Schneider, I., Meyer, H., Neubronner, J., von Schacky, C., & Hahn, A. (2011) · Lipids in Health and Disease · doi:10.1186/1476-511x-10-145 · Cited by 291 · cited 1×
“Several studies have attempted to compare the bioavailability of TAG- or PLenriched sources of DHA based on responses of blood biomarkers and have concluded either higher bioavailability of PL-DHA [31-33] or equal efficacy [34-37], although this area is controversial [38-41].”
BackgroundHDL and cholesterol handling in the brain
Vitali, C., Wellington, C. L., & Calabresi, L. (2014) · Cardiovascular Research · doi:10.1093/cvr/cvu148 · Cited by 254 · cited 1×
“It has been proposed that small HDL particles can enter the brain through the action of scavenger receptor class B, type I (SR-BI) on brain capillary endothelial cells [64-66], suggesting a possible mechanism for the higher brain tracer uptake in [U3 H]PC-DHA-gavaged rats compared with [U3 H]TAG-DHA.”
ResultAstarita, G., Jung, K.-M., Berchtold, N. C., Nguyen, V. Q., Gillen, D. L., Head, E., Cotman, C. W., & Piomelli, D. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012538 · Cited by 218 · cited 2×
“found in patients with Alzheimer’s disease [7-11] (reviewed in [12]).”
BackgroundRamprasath, V. R., Eyal, I., Zchut, S., & Jones, P. J. (2013) · Lipids in Health and Disease · doi:10.1186/1476-511x-12-178 · Cited by 175
Vaisman, N., Kaysar, N., Zaruk-Adasha, Y., Pelled, D., Brichon, G., Zwingelstein, G., & Bodennec, J. (2008) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/87.5.1170 · Cited by 160 · cited 1×
“Several studies have attempted to compare the bioavailability of TAG- or PLenriched sources of DHA based on responses of blood biomarkers and have concluded either higher bioavailability of PL-DHA [31-33] or equal efficacy [34-37], although this area is controversial [38-41].”
BackgroundLiu, L., Bartke, N., Van Daele, H., Lawrence, P., Qin, X., Park, H. G., Kothapalli, K., Windust, A., Bindels, J., Wang, Z., et al. (2014) · Journal of Lipid Research · doi:10.1194/jlr.m045930 · Cited by 117 · cited 6×
“presently is consistent with previous work in which only the sn-2 DHA is labelled [42, 43], indicating that this higher brain radioactivity in [U3 H]PC-DHA rats was, at least in part, due to higher brain uptake of the [ 3 H]DHA moiety.”
BackgroundMethodResultInfluential
Cited by
Health benefits of dietary marine DHA/EPA-enriched glycerophospholipids
Zhang, T.-T., Xu, J., Wang, Y.-M., & Xue, C.-H. (2019) · Progress in Lipid Research · doi:10.1016/j.plipres.2019.100997 · Cited by 339
Lust, C. A. C., Mountjoy, M., Robinson, L. E., Oliver, J. M., & Ma, D. W. L. (2020) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2019-0555 · Cited by 24
Wu, F., Wang, D.-D., Wen, M., Che, H.-X., Xue, C.-H., Yanagita, T., Zhang, T.-T., & Wang, Y.-M. (2017) · Lipids in Health and Disease · doi:10.1186/s12944-017-0623-2 · Cited by 20
Metadata
- Authors
- Kitson, A. P., Metherel, A. H., Chen, C. T., Domenichiello, A. F., Trépanier, M.-O., Berger, A., & Bazinet, R. P.
- Venue
- The Journal of Nutritional Biochemistry
- Publisher
- Elsevier BV
- Published
- 2016-07
- Volume
- 33
- Pages
- 91-102
- ISSN
- 0955-2863 (ISSN-L)
- OpenAlex
- W2310020475
- Cited by
- 106
- References
- 8
- FWCI
- 11.60
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effect of dietary docosahexaenoic acid (DHA) in phospholipids or triglycerides on brain DHA uptake and accretion. https://app.cochat.ai/papers/10.1016/j.jnutbio.2016.02.009
- The paper
- Kitson, A. P., Metherel, A. H., Chen, C. T., Domenichiello, A. F., Trépanier, M.-O., Berger, A., & Bazinet, R. P. (2016). Effect of dietary docosahexaenoic acid (DHA) in phospholipids or triglycerides on brain DHA uptake and accretion. The Journal of Nutritional Biochemistry. https://doi.org/10.1016/j.jnutbio.2016.02.009
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.